Brief: 9 Meters Biopharma Inc As Of Dec 31 Had Total Cash And Cash Equivalents Of About $29.7 Million
March 28 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* AS OF DECEMBER 31, 2022, HAD TOTAL CASH AND CASH
EQUIVALENTS OF
ABOUT $29.7 MILLION
* QTRLY NET LOSS PER SHARE WAS $0.92
* Q4 EARNINGS PER SHARE VIEW $-0.76 -- REFINITIV IBES DATA
* EXPECTS COMPLETION OF A PRE-IND MEETING FOR NM-136
FOLLOWED BY
POTENTIAL IND SUBMISSION IN THE SECOND HALF OF 2023
Source text for Eikon: ID:
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection